Matthew Hamilton Rosenberg’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35
Closed -$4.77K 822
2025
Q4
$4.77K Hold
35
﹤0.01% 692
2025
Q3
$5.16K Hold
35
﹤0.01% 692
2025
Q2
$4.53K Hold
35
﹤0.01% 729
2025
Q1
$4.18K Hold
35
﹤0.01% 718
2024
Q4
$4.06K Hold
35
﹤0.01% 710
2024
Q3
$4.73K Hold
35
﹤0.01% 698
2024
Q2
$4.6K Hold
35
﹤0.01% 667
2024
Q1
$4.5K Hold
35
﹤0.01% 710
2023
Q4
$4K Hold
35
﹤0.01% 722
2023
Q3
$3.19K Hold
35
﹤0.01% 724
2023
Q2
$3.94K Hold
35
﹤0.01% 710
2023
Q1
$3.67K Hold
35
﹤0.01% 751
2022
Q4
$3.87K Hold
35
﹤0.01% 737
2022
Q3
$3K Hold
35
﹤0.01% 754
2022
Q2
$3K Buy
+35
New +$2.89K ﹤0.01% 741

Other funds holding XYL

Matthew Hamilton Rosenberg's XYL Position: Q1 2026 in Review

Matthew Hamilton Rosenberg sold out of Xylem (XYL) in Q1 2026, closing a stake of 35 shares — an estimated $4.77K sold.

Matthew Hamilton Rosenberg first reported a position in XYL in Q2 2022 and held it in 15 quarters. The position peaked at $5.16K in Q3 2025. 1,114 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Matthew Hamilton Rosenberg reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 35 Xylem shares in Q1 2026, an estimated $4.77K.
  • Matthew Hamilton Rosenberg first reported a position in Xylem in Q2 2022 and held it in 15 quarters.
  • Matthew Hamilton Rosenberg's Xylem position peaked at $5.16K in Q3 2025.
  • 1,114 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2026, filed 7 Apr 2026.